Posted on

A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain.

Michael A Überall has received direct and/or indirect financial support in form of research grants, honorarium for consultancy, scientific advice, and/or lecture activities from Almirall, Aristo Pharma, Berlin Chemie, Bionorica, Esanum, Glaxo Smith Kline, Grünenthal, Hapa Medical, Hexal, Kyowa-Kirin, Lilly, Menarini, Mucos, Mundipharma, Novartis, Pfizer, Pharm Allergan, Servier, SGP Pharma, Shionogi, Teva, and Tilray. The author reports no other conflicts of interest in this work.

L’article A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain. est apparu en premier sur Cannabis Belgique.